CAM
UTHR icon

ClariVest Asset Management’s United Therapeutics UTHR Stock Holding History

ClariVest Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$24.5K Hold
77
– – ﹤0.01% 376
2024
Q2 		$24.5K Buy
77
+42
+120% +$11.1K ﹤0.01% 376
2024
Q1 		$8.04K Buy
35
+8
+30% +$1.8K ﹤0.01% 426
2023
Q4 		$5.94K Hold
27
– – ﹤0.01% 440
2023
Q3 		$6K Hold
27
– – ﹤0.01% 430
2023
Q2 		$6K Sell
27
-30
-53% -$6.64K ﹤0.01% 424
2023
Q1 		$13K Sell
57
-5
-8% -$1.23K ﹤0.01% 438
2022
Q4 		$17K Hold
62
– – ﹤0.01% 445
2022
Q3 		$13K Hold
62
– – ﹤0.01% 439
2022
Q2 		$15K Sell
62
-5,761
-99% -$1.17M ﹤0.01% 453
2022
Q1 		$1.04M Sell
5,823
-2
-0% -$381 0.04% 283
2021
Q4 		$1.26M Hold
5,825
– – 0.04% 289
2021
Q3 		$1.08M Buy
5,825
+120
+2% +$23.6K 0.03% 309
2021
Q2 		$1.02M Hold
5,705
– – 0.03% 293
2021
Q1 		$955K Buy
5,705
+1,042
+22% +$174K 0.03% 293
2020
Q4 		$708K Buy
4,663
+4,632
+14,942% +$608K 0.02% 322
2020
Q3 		$3K Hold
31
– – ﹤0.01% 601
2020
Q2 		$4K Buy
+31
New +$3.49K ﹤0.01% 654
2016
Q2 		– Sell
-12
Closed -$1K – 695
2016
Q1 		$1K Hold
12
– – ﹤0.01% 608
2015
Q4 		$2K Hold
12
– – ﹤0.01% 557
2015
Q3 		$2K Sell
12
-7
-37% -$1.12K ﹤0.01% 536
2015
Q2 		$3K Sell
19
-20,859
-100% -$3.75M ﹤0.01% 528
2015
Q1 		$3.6M Sell
20,878
-296
-1% -$45.1K 0.11% 123
2014
Q4 		$2.74M Sell
21,174
-144
-0.7% -$18.6K 0.1% 116
2014
Q3 		$2.74M Sell
21,318
-20
-0.1% -$2.06K 0.1% 130
2014
Q2 		$1.89M Sell
21,338
-7,625
-26% -$733K 0.07% 177
2014
Q1 		$2.72M Buy
28,963
+2,799
+11% +$286K 0.11% 133
2013
Q4 		$2.96M Buy
26,164
+10,205
+64% +$920K 0.12% 124
2013
Q3 		$1.26M Sell
15,959
-2,400
-13% -$175K 0.06% 197
2013
Q2 		$1.21M Buy
+18,359
New +$1.18M 0.05% 200

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

ClariVest Asset Management's UTHR Position: Q3 2024 in Review

ClariVest Asset Management held its United Therapeutics (UTHR) position steady in Q3 2024 at 77 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #376.

ClariVest Asset Management first reported a position in UTHR in Q2 2013 and has held it in 30 quarters since. The position peaked at $3.6M in Q1 2015. 624 funds tracked by Wall St. Rank hold UTHR as of Q3 2024.

  • ClariVest Asset Management held 77 shares of United Therapeutics worth $24.5K as of Q3 2024.
  • ClariVest Asset Management left its United Therapeutics share count unchanged in Q3 2024.
  • United Therapeutics made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #376 holding.
  • ClariVest Asset Management first reported a position in United Therapeutics in Q2 2013 and has held it in 30 quarters since.
  • ClariVest Asset Management's United Therapeutics position peaked at $3.6M in Q1 2015.
  • 624 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.